Deskside with Dr. Dan
FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma
Dr. Dan, Gryt Health’s Chief Medical Officer breaks down the takeaways of this new approval from January 2021.
Liz Hiles
July 7, 2022
